Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A drug that mimics the female hormone ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Pittsburgh-based insurer Highmark is further expanding its drug offerings through CivicaScript and leaning on biosimilars as ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...